This brief examines what the November election and prior efforts to enshrine abortion rights at the ballot box mean for those states and what’s next, including the future of abortion restrictions in states where voters enshrined abortion rights where abortion was banned or restricted, as well as those that do not have abortion bans.

KFF | Healthcare Policy Issues

20.12.2024

A New Reproductive Health Landscape? Possible Actions that Could be Undertaken During the Second Trump Administration | KFF

This brief reviews some of the possible actions of the incoming Trump administration and new Congress based on campaign statements, policies implemented by the first Trump administration, and proposals forwarded by allied conservative think tanks and antiabortion advocacy groups.

KFF | Healthcare Policy Issues

20.12.2024

How Medicare Negotiated Drug Prices Compare to Other Countries | KFF

This analysis finds that Medicare's negotiated prices for 10 high-expenditure prescription drugs are lower than what private Medicare drug plans had been paying, but still much higher than the prices available in 11 other wealthy nations.. It is available on the Peterson-KFF Health System Tracker.

KFF | Healthcare Policy Issues

20.12.2024

Myths About Raw Milk and Vaccines - KFF Health Misinformation Monitor | KFF

This volume explores narratives linking vaccines to autism and misleading claims about the benefits of raw milk. It examines how trust and perceived expertise influence misinformation and AI's role in spreading false mental health information.

home›KFF | Healthcare Policy Issues

KFF | Healthcare Policy Issues

Health

What’s Next for State Abortion Ballot Initiatives? | KFF

A New Reproductive Health Landscape? Possible Actions that Could be Undertaken During the Second Trump Administration | KFF

How Medicare Negotiated Drug Prices Compare to Other Countries | KFF

Myths About Raw Milk and Vaccines - KFF Health Misinformation Monitor | KFF

home
›
KFF | Healthcare Policy Issues